- Home
- AIRE vs VYNE Comparison
AIRE vs VYNE Comparison
Compare AIRE & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- VYNE
- Stock Information
- Founded
- AIRE 2021
- VYNE 2003
- Country
- AIRE United States
- VYNE United States
- Employees
- AIRE 132
- VYNE N/A
- Industry
- AIRE
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- AIRE
- VYNE Health Care
- Exchange
- AIRE Nasdaq
- VYNE Nasdaq
- Market Cap
- AIRE 13.9M
- VYNE 16.0M
- IPO Year
- AIRE N/A
- VYNE 2018
- Fundamental
- Price
- AIRE $0.26
- VYNE $1.42
- Analyst Decision
- AIRE Strong Buy
- VYNE Strong Buy
- Analyst Count
- AIRE 1
- VYNE 2
- Target Price
- AIRE $1.25
- VYNE $6.25
- AVG Volume (30 Days)
- AIRE 3.2M
- VYNE 1.3M
- Earning Date
- AIRE 08-21-2025
- VYNE 08-13-2025
- Dividend Yield
- AIRE N/A
- VYNE N/A
- EPS Growth
- AIRE N/A
- VYNE N/A
- EPS
- AIRE N/A
- VYNE N/A
- Revenue
- AIRE $1,853,629.00
- VYNE $605,000.00
- Revenue This Year
- AIRE $369.52
- VYNE $42.51
- Revenue Next Year
- AIRE $68.67
- VYNE N/A
- P/E Ratio
- AIRE N/A
- VYNE N/A
- Revenue Growth
- AIRE 1925.60
- VYNE 43.03
- 52 Week Low
- AIRE $0.24
- VYNE $0.85
- 52 Week High
- AIRE $4.49
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- AIRE 23.85
- VYNE 55.43
- Support Level
- AIRE $0.24
- VYNE $1.20
- Resistance Level
- AIRE $0.34
- VYNE $1.50
- Average True Range (ATR)
- AIRE 0.03
- VYNE 0.23
- MACD
- AIRE 0.00
- VYNE 0.01
- Stochastic Oscillator
- AIRE 15.58
- VYNE 49.53
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.